Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
1.520
+0.040 (2.70%)
At close: Aug 29, 2025, 4:00 PM
1.490
-0.030 (-1.97%)
After-hours: Aug 29, 2025, 4:14 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Regulatory Ribonucleic Acid-based Therapeutics
652.00K
Log In
Regulatory Ribonucleic Acid-based Therapeutics Growth
86.29%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
652.00K
Log In
United States Growth
86.29%
Log In